alexa Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Long After Achieving Hbsag Seroconversion: A Need for an Improved Hepatitis B Virus DNA Assay | Abstract
ISSN: 2327-5073

Clinical Microbiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Long After Achieving Hbsag Seroconversion: A Need for an Improved Hepatitis B Virus DNA Assay

She-Yan Wong1Xiangdong David Ren2Hie-Won Hann1,3*

1Division of Gastroenterology and Hepatology, Department of Medicine, USA

2Reniguard Life Sciences Inc, Exton, USA

3Liver Disease Prevention Center, Jefferson Medical College, Thomas Jefferson University Hospital, USA

*Corresponding Author:
Hie-Won Hann
Liver Disease Prevention Center, Division of Gastroenterology and Hepatology
Department of Medicine, Jefferson Medical College
Thomas Jefferson University Hospital, USA
Tel: 1-215-955- 5806
Fax: 1-215-955-0770
E-mail: [email protected]

Received Date: July 25, 2013; Accepted Date: August 19, 2013; Published Date: August 21, 2013

Citation: Wong SY, Ren XD, Hann HW (2013) Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Long After Achieving Hbsag Seroconversion: A Need for an Improved Hepatitis B Virus DNA Assay. Clin Microbial 2:127. doi: 10.4172/2327-5073.1000127

Copyright: © 2013 Wong SY, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

The ultimate goal of antiviral treatment is prevention of hepatocellular carcinoma (HCC). Currently the end point of successful antiviral treatment for patients with chronic hepatitis B is to achieve HBsAg loss or HBsAg seroconversion. We report two patients who successfully developed anti-HBs with or without antiviral therapy and yet developed HCC. Initial commercial assay showed negative HBV DNA for both patients. However, they were found to have detectable HBV DNA by a new laboratory-developed HBV DNA assay. These cases show that patients with HBsAg seroclearance continue to be at risk for HCC and surveillance for HCC should be continued. The diagnosis of occult hepatitis B with an improved HBV DNA assays is also necessary as it is important for treatment for chronic HBV and prevention of HCC.

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version